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Goris Nazari1*, Pavlos Bobos1, Joy C. MacDermid1,2, Kathryn E. Sinden3, Julie Richardson4 and Ada Tang4

Abstract
Background: Technological development and improvements in Wearable Physiological Monitoring devices, have
facilitated the wireless and continuous field-based monitoring/capturing of physiologic measures in healthy, clinical
or athletic populations. These devices have many applications for prevention and rehabilitation of musculoskeletal
disorders, assuming reliable and valid data is collected. The purpose of this study was to appraise the quality and
synthesize findings from published studies on psychometric properties of heart rate measurements taken with the
Zephyr Bioharness device.
Methods: We searched the Embase, Medline, PsycInfo, PuMed and Google Scholar databases to identify articles.
Articles were appraised for quality using a structured clinical measurement specific appraisal tool. Two raters evaluated
the quality and conducted data extraction. We extracted data on the reliability (intra-class correlation coefficients and
standard error of measurement) and validity measures (Pearson/Spearman’s correlation coefficients) along with mean
differences. Agreement parameters were summarised by the average biases and 95% limits of agreement.
Results: A total of ten studies were included: quality ratings ranged from 54 to 92%. The intra-class correlation
coefficients reported ranged from 0.85–0.98. The construct validity coefficients compared against gold standard
calibrations or other commercially used devices, ranged from 0.74–0.99 and 0.67–0.98 respectively. Zephyr Bioharness
agreement error ranged from − 4.81 (under-estimation) to 3.00 (over-estimation) beats per minute, with varying 95%
limits of agreement, when compared with gold standard measures.
Conclusion: Good to excellent quality evidence from ten studies suggested that the Zephyr Bioharness device can
provide reliable and valid measurements of heart rate across multiple contexts, and that it displayed good agreements
vs. gold standard comparators – supporting criterion validity.
Keywords: Zephyr bioharness, Psychometric properties, Reliability, Validity, Agreement, Wearable device, Heart rate,
Quality evidence

Background
Technological development and improvements in
Wearable Physiological Monitoring (WPM) devices,
have facilitated the wireless, long range and continuous field-based monitoring/capturing of physiologic
measures in healthy, clinical or athletic populations
[1–3]. Numerous WPM devices have been introduced to the market [4, 5] with a range of capabilities and target audiences.
The Zephyr Bioharness ™ (Zephyr Technology Corporation, Annapolis, MD, US) is a wireless chest-based wearable
* Correspondence: gnazari@uwo.ca
1
Physical Therapy, Western University, London, ON, Canada
Full list of author information is available at the end of the article

device, capable of real-time and long-distance recording of
various physiological parameters, including heart rate, respiratory rate, core temperature, activity levels and posture
[6]. The device can capture data for 26 h, includes a BioModule, weighs 85 g and fits on the chest at lower sternum for
both men and women [6]. The BioModule is snapped into
an adjustable belt. The belt (chest strap) contains skin conductive electrodes to captures heart rate through recording
of cardiac electric impulses, and produces an output in beats
per minute. Heart rate monitoring offers several advantages.
Calculating the percentage of maximum heart rate, is a
commonly used approach to monitor exercise intensity. [7].
Among athletes (soccer players), submaximal exercises heart
rate monitoring has shown to be highly predictive of
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improvements in physical performance (i.e. maximal aerobic speed) [8]. In addition, during steady-state exercise,
the linear relationship between heart rate and the rate of
oxygen consumption has shown to be an effective method
to assess training internal load [9]. This linear relationship
can also be used to estimate maximal oxygen uptake
VO2max [10]. Furthermore, in both trained individuals
and athletes, monitoring of heart rate recovery has been
suggested as a potential marker to evaluate training status,
which is, in turn, used to optimize training programs [11].
It has been proposed that heart rate measures can be used
to provide an estimate of energy expenditure, providing
an easier and inexpensive alternative [12].
It is important for a device to be reliable (provide
consistent scores in stable conditions), valid (provide
true scores) and be responsive (to detect change
over time) if it is to be used to assess/support performance or decision-making [13, 14]. Reliability is
measured in both relative and absolute terms. Relative reliability – a correlation coefficient, comments
on the ability of a device to differentiate between
participants, whereas absolute reliability emphasizes
on the measurement error in the same unit of original measurement [13]. In order for a device to be
useful (reliable), its relative reliability needs to be
sufficiently large, and absolute reliability sufficiently
small [13]. A device can be reliable but not valid
[13]. Validity can be assessed in a variety of ways,
but ideally is established by comparing devices to an
established “gold standard” criterion measure, with
criterion validity established when a new device can
provide the same measurement as the standard [15].
In addition, neither the reliability nor the validity
measurement properties of a device can be used to
detect change over time (improvements or deteriorations). Reporting of the responsiveness parameters of
a device, deals with its ability to assess change over
time [13, 14].
Individual measurement studies often address some
domains of measurement, but do not provide comprehensive assessments [16–18]. Systematic reviews of
measurement studies allow for one to understand the
measurement properties across a variety of contexts,
populations and measurement purposes. By using a
structured clinical measurement specific appraisal tool,
we are able to focus on higher quality research when
synthesizing measurement research [16–18].
Considering heart rate and its wide-spread application,
and the need to synthesis and provide a comprehensive
evidence on the accumulating measurement properties of
Zephyr Bioharness device, the aims of this systematic review were to synthesize and critically appraise the measurement studies where a Zephyr Bioharness device was
used to measure heart rate.
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Methods
Search

To identify articles on psychometric properties of
Zephyr Bioharness device, we searched the Embase,
Medline, PsycInfo, PuMed and Google Scholar databases
between January 2010 – January 2017, using the following keywords: Zephyr Bioharness OR ZB) AND (heart
rate OR psychometric properties OR measurement
properties OR reliability OR minimal detectable change
OR validity OR responsiveness OR minimal clinical important difference OR agreement. Further articles were
also identified by examining the reference list of each selected study. We were specifically interested in Zephyr
Bioharness device, which has been introduced into the
market at year 2010, so we limited our search to this
year because we did not any expect publications prior to
that year.
Selection of studies

At the first stage, two authors independently identified
and screened Title/abstract. Studies that had used the
device to monitor physiological measures only, without
reporting of psychometric properties were considered irrelevant. An article was accepted if it met following specific eligibility criteria:
Inclusion Criteria:
1. Purpose of the study states assessing reliability or
validity or responsiveness or agreement parameters,
of Zephyr Bioharness heart rate variable in healthy
or clinical population.
2. Articles published in English,
Exclusion Criteria:
1. No data on the psychometric properties of Zephyr
Bioharness heart rate variable.
2. Studies that had used Zephyr Bioharness device to
monitor physiological responses only.
Data extraction

The primary author G. N., and secondary author P. B.
conducted the data extractions. For reliability measures,
Standard Error of Measurement (SEM), intra-class correlation coefficient (ICC), mean differences and confidence intervals were extracted [16–18]. These were
interpreted using a common benchmark where ICC <
0.40 indicate poor, 0.40 ≤ ICC < 0.75 indicate fair to good
and ICC ≥ 0.75 indicate excellent reliability [19]. For
construct validity where these devices were compared
against a reference standard, Pearson’s/Spearman’s correlation coefficients and mean difference data were extracted [16–18]. The absolute value for the strength of
the correlation were determined using the guide
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Fig. 1 The systematic review evidence flowchart

suggested by Evans [20] as follows; 0.00–0.19 “very
weak”, 0.20–0.39 “weak”, 0.40–0.59 “moderate”, 0.60–
0.79 “strong”, 0.80–1.00 “very strong”. To assess levels of
agreement, agreement bias along with 95% Limits of
Agreement (LoA) were extracted. This uniquely evaluates whether there is a discrepancy (bias) between two
different devices measuring the same construct [21].
Quality appraisal

The articles were appraised by the first (G. N.) and second (P. B.) authors for quality using a structured clinical
measurement specific appraisal tool [16–18]. This quality tool has previously demonstrated high reliability in
evaluating the quality of clinical measurement studies
for musculoskeletal outcome measures [18]. The evaluation criteria included: 1) Thorough literature review to
define the research question; 2) Specific inclusion/

exclusion criteria; 3) Specific hypotheses; 4) Appropriate
scope of psychometric properties; 5) Sample size; 6)
Follow-up; 7) The authors referenced specific procedures for administration, scoring, and interpretation of
procedures; 8) Measurement techniques were standardized; 9) Data were presented for each hypothesis; 10)
Appropriate statistics-point estimates; 11) Appropriate
statistical error estimates; and 12) Valid conclusions and
recommendations [16–18] (Additional file 1). An article’s total quality score was calculated by summing of
scores for each item, divided by the numbers of items
and multiplied by 100% [16–18]. Quality summary of appraised papers that ranged from (0%–30%) was marked
as Poor, (31%–50%) as Fair, (51%–70%) as Good, (71%–
90%) as Very Good, and (> 90%) as Excellent [16, 17].
When individual appraisals varied, we used the below
consensus procedures:
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1. We first identified the variations in individual
appraisals.
2. To resolve scoring discrepancies based on factual
content, the original articles were reassessed.
3. To resolve scoring discrepancies based on extent of
compliance with the item, the raters (G.N.) and
(P.B.) consulted the third author/instrument
developer (J.M.).
4. The first and the second authors further discussed
their understanding of how well articles complied
with each item of the appraisal tool. The most
common source of score discrepancies were oversight.

Results
A total of 147 studies were identified from the search in
the databases [Embase (n = 29), Medline (n = 19), PsycInfo (n = 1), PubMed (n = 58) and Google Scholar (n =
40)], of which 61 studies were considered relevant. All
61 studies were retrieved and assessed for eligibility, and
a total of 10 studies were included in this review (Fig. 1).
Table 1 displays the summary of the studies addressing
the psychometrics of Zephyr Bioharness device. The
quality of the studies ranged from 54 to 92%, with 80%
of articles reaching or exceeding a score of 67% on the
quality rating (Fig. 1 & Table 2). The most common
flaws noted in were 1) lack of specific hypotheses, 2) not
considering an appropriate scope of psychometric properties/ lack of specific inclusion or exclusion criteria,
and 3) lack of a sample size calculation/justification.
Zephyr bioharness heart rate reliability

We located four studies that examined the test-retest reliability measures of Zephyr Bioharness [Table 3] during
different physical activities including rest, recovery
phases and unstructured mobility; vacuuming and
sweeping, and structure running/walking, cycling and
submaximal activity [1, 2, 22, 23]. The populations studied included young healthy recreational active males and
females across various age groups as well as older patients with atrial fibrillation [1, 2, 22, 23].
Overall, ZB heart rate variable displayed excellent reliability properties. This included a SEM ranging from
2.11–5.90 beats per minute and, excellent test re-test reliability coefficients ≥0.85 [1, 2, 22, 23].
Zephyr bioharness heart rate validity

We identified two studies that assessed the validity of ZB
heart rate variable against other commercially used devices (Polar T31) [1, 24], and six studies that assessed validity against gold standard criterion measure (ECG)
[Table 4] [22, 25–29]. Validity measures were established
at resting, physical activity, and recovery phases, including
both healthy recreational active males and females, as well
as older patients with atrial fibrillation [1, 22, 24–29].
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Table 1 Summary of studies addressing psychometric
properties of ZB
Study

Sample

n

Johnstone
et al.
(2012). [1]

Ten physically active
males, age 21.5 ± 2.8
years, weight 71.4 ± 7.9 kg
and height 1.79 ± 0.1 m.

10 Reliability,
concurrent
validity &
agreement.

Treadmill walk-jogrun.

Johnstone
et al.
(2012a).
[24]

Twenty-two physically
active males,
age 21.5 ± 2.8
years, weight 71.4 ± 7.9 kg
and height 1.79 ± 0.10 m.

22 Concurrent
validity &
agreement.

Treadmill walking
and running.

Johnstone Ten physically
et al.
active males, age
(2012b). [2] 20.5 ± 2.1 years,
weight 70.4 ± 9.4 kg
and height 1.77 ± 0.10 m.

10 Reliability.

Treadmill running.

Kim et al.
Twelve healthy
(2013). [25] men, age 25.5 ± 4.1,
height 180.1 ± 6.5
and weight 78.8 ± 13.9.

12 Validity &
agreement.

Treadmill running.

Gatti et al. Seven healthy
(2014). [26] males and three females,
Age 23.8 ± 2.9 years,
height 179 ± 8 cm
and weight 75.5 ± 10.7 kg.

10 Validity &
agreement.

Sitting, thoracic
rotation, arm Lifting,
Batting, Weightmoving, Walking.

Smith et
al. (2014).
[29]

Eleven healthy men
age 20.0 ± 1.0 years,
height 1.80 ± 0.07 m
and weight 82.0 ± 10.2 kg.

11 Validity &
agreement.

Treadmill walk,
search (crawl), stairs.

Dolezal et
al. (2014).
[28]

Ten healthy men,
age 21.0 ± 1.0 years,
height 184 ± 5 cm
and weight 91 ± 10 kg.

10 Criterion
validity &
agreement.

Treadmill walk,
search (crawl), stairs,
fast walk.

75 Concurrent
validity &
agreement.

Cycle ergometery
(rest, 12-stages of
cycle ergometer
and recovery).

Rawstorn
et al.
(2015).
[22].

Six recreationally
10 Reliability,
active males and four
8 validity &
females, Age 26.68 ± 3.26
agreement.
years, weight
71.10 ± 11.53 kg
and height 1.73 ± 0.06 m.
Five males and three
females with atrial
fibrillation,
Age 69.68 ± 9.53 years,
weight 77.46 ± 18.81
kg and height 1.69 ± 0.12 m.

Treadmill running.
Treadmill, cycle
ergometery and
activities of daily
living: sweep and
vacuum.

Nazari et
al. (2017).
[23]

Thirty healthy males
48.0 ± 15 years, body
mass index 25.0 ± 2.30
kg/m2, and 30 females
30 females, 48.0 ± 15
years, body mass
index 24.0 ± 3.50.

Rest, sub-maximal
activity, recovery.

Flanagan
Seventy-five healthy men,
et al.
age 23 ± 4 years,
(2014). [27] height 181 ± 8 cm
and weight 83 ± 12 kg.

Properties
evaluated

60 Reliability

Testing protocol

In summary, the ZB displayed strong to very strong
correlations of ≥0.67 during physical activity phases
when compared with Polar T31 device [1, 24]. In
addition, the device demonstrated very strong correlations of ≥0.87 at rest [25–27], strong to very strong correlations of ≥0.74 during various activities [22, 25–29]
and very strong correlations of ≥0.99 throughout recovery [27] when compared with a gold standard criterion
measure (ECG).
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Table 2 Quality of studies on the psychometric properties oF ZB
Study

Item evaluation criteria a
1

2

3

4

5

6

7

8

9

10

11

12

Total (%)

Nazari et al. (2017). [23]

2

2

2

1

2

2

2

2

2

2

1

2

92

Johnstone et al. (2012). [1]

2

1

1

1

0

2

2

2

2

2

2

2

79

Johnstone et al. (2012a). [24]

2

1

1

1

0

NA

2

2

1

2

2

2

73

Flanagan et al. (2014). [27]

1

1

1

1

1

NA

2

2

2

2

1

2

73

Smith et al. (2014). [29]

2

1

1

1

0

NA

2

2

1

2

2

1

68

Dolezal et al. (2014). [28]

1

1

1

1

0

NA

2

2

2

2

1

2

68

Kim et al. (2013). [25]

2

1

1

1

0

NA

2

2

1

2

1

1

64

Rawstorn et al. (2015). [22]

1

1

1

1

0

2

2

2

1

2

1

1

63

Johnstone et al. (2012b). [2]

2

1

1

0

0

0

2

2

1

2

1

2

58

Gatti et al. (2014). [26]

1

1

0

1

0

NA

2

2

1

2

1

1

54

Total score = (sum of subtotals ÷ 24 × 100). If for a specific paper an item is deemed NA (Not Applicable), then, Total score = (sum of subtotals ÷ (2 × number of
Applicable items) × 100)
Quality Summary: Poor (0%–30%), Fair (31%–50%), Good (51%–70%), Very good (71%–90%), Excellent (> 90%):
NA not applicable. The subsections no. 6, asks for percentage of retention/follow up. This subsection only applies to reliability test-retest studies
a
Item Evaluation Criteria: 1. Thorough literature review to define the research question; 2. Specific inclusion/exclusion criteria; 3. Specific hypotheses; 4.
Appropriate scope of psychometric properties; 5. Sample size; 6. Follow-up; 7. The authors referenced specific procedures for administration, scoring, and interpretation of procedures; 8. Measurement techniques were standardized; 9. Data were presented for each hypothesis; 10. Appropriate statistics-point estimates; 11. Appropriate statistical error estimates; 12. Valid conclusions and clinical recommendations

Zephyr bioharness heart rate agreement

We identified two studies that assessed the pair-wise
agreement between ZB heart rate measure with Polar
T31 device [1, 24], and six studies that assessed the
pair-wise agreement between ZB heart rate measure

Table 3 Summary of reliability properties of ZB
Study

Testing
protocol

Johnstone et al.
(2012). [1]

Walk-Jog-Run

ICC

SEM/CV

Mean 95% C.I.
diff.

All Velocities

0.97 4.60 (CV) 4.30

−4.56 – 3.92

4–6 km/h

0.89 5.90 (CV) −
0.20

− 2.40 – −
1.23

8–10.5 km/h

0.93 4.10 (CV) 5.10

−5.55 – −
4.71

11.0 km/h

0.85 2.80 (CV) 5.60

−6.32 – −
4.82

Johnstone et al.
(2012b). [2]

Treadmill
Running

0.98 4.80 (CV) 2.70

−3.15 – 2.22

Rawstorn et al.
(2015). [22]

Treadmill
Running

0.98 5.20
(SEM)

–

–

Treadmill, Cycle 0.98 4.77
Ergometer and
(SEM)
Activities of daily
living; sweep
and vacuum

–

–

Rest

0.92 2.11
(SEM)

0.21

−3.93 – 4.35

Submaximal
activity

0.94 3.50
(SEM)

2.82

−4.04 – 9.68

Recovery

0.90 3.51
(SEM)

1.56

−5.31 – 8.43

Nazari et al.

\(2017). [23]

ZB zephyr bioharness, ICC intra-class correlation coefficient, SEM standard error
of measurement, CV coefficient of variation, Mean diff mean difference, 95%
C.I. confidence interval

with gold standard criterion measure (ECG) [Table 5]
[22, 25–29].
Three studies reported heart rate biases of ≤3.00 beats
per minute with (− 3.10–2.42) 95% limits of agreement
in pairwise device comparison of ZB at rest, recovery
phases or during various activities against ECG [27–29].
Furthermore, the inter-device agreement between ZB and
Polar T31 heart rate measures yielded agreement biases of
≤3.05 with (− 79.20–79.20) 95% limits of agreement during a treadmill walk/run testing protocols [1, 24].
Overall, ZB heart rate variable displayed better agreements (i.e. narrower limits of agreement) with ECG than
with Polar T31 device, supporting criterion validity and
suggestive of possible interchangeable use [1, 22, 24–29].

Discussion
After synthesizing ten studies addressing the measurement properties of the Zephyr Bioharness device, we
conclude that there is good to excellent quality evidence
supporting the reliability and validity of this device. This
review suggests that the Zephyr Bioharness device can
provide reliable and valid measurements of heart rate
across multiple contexts, and that it might be useful for
prevention or rehabilitation applications where fieldbased monitoring of heart rate is required in low risk patient populations. The use of the devices in high-risk
populations was not studied.
In regards to ZB reliability parameters, four studies
were identified [1, 2, 22, 23]. The included studies reported sufficiently large relative reliability scores, and
sufficiently small absolute reliability measures. All four
identified studies reported excellent ICC ≥ 0.85 (SEM ≤
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Table 4 Summary of validity properties of ZB
Study

Criterion
measure

Johnstone et Polaral. (2012a).
T31.
[24]

Mean
diff.

r/rs

Study

Criterion Testing protocol
measure

Agreement 95%
bias
LoA

Treadmill – Walking and
Running

−3.80

0.89

Johnstone
et al.
(2012a).
[24]

PolarT31.

Treadmill
– Walking
and Running

−3.05

−32.20
– 32.20

0.00

0.98

PolarT31

Walk-Jog-Run

0.02

−79.20
– 79.20

4–6 km/h

1.30

0.92

Johnstone
et al.
(2012). [1]

8–10.5 km/h

− 0.70 0.93

0.50

11.0 km/h

−2.10

0.67

Kim et al.
12-Lead Treadmill running
(2013). [25] ECG

−15.30
– 16.30

3.20

0.87

Flanagan
5 Lead
et al.
ECG
(2014). [27]

3.00

−2.84
– 2.42

1.00

≥0.99

−0.05
– 0.12

12- Stages

0.00

≥0.99

Dolezal et
al. (2014).
[28]

0.04

Rest

Search (Crawl)

−0.01

Recovery

2.00

≥0.99

− 0.12
– 0.10

Treadmill Walk

0.04

0.99

Stairs

−0.13

Search (Crawl)

− 0.01 0.99

−0.21
–−
0.04

Stairs

−0.13

0.99

Fast walk

0.03

Fast walk

0.03

0.99

−0.09
– 0.14

−0.40

Treadmill Walk

Treadmill Walk

0.99

− 0.40

Search (Crawl)

−1.70

0.95

−0.70
–−
0.10

Stairs

0.40

0.99

Search (Crawl)

−1.70

Sitting

−0.78

−3.1 –
−0.40

0.99

−0.77

Stairs

0.40

Thoracic rotation.

0.98

0.04–
0.70

Arm Lifting.

0.22

0.94

Sitting

−0.78

Batting.

−2.51

0.76

−5.10
– 3.60

Weight moving.

−4.81

0.78

Thoracic rotation.

−0.77

Walking.

−1.68

−5.40
– 3.90

0.74

Arm Lifting.

0.22

Treadmill Running

−1.30

0.92

−7.70
– 8.10

Treadmill, Cycle Ergometer
and Activities of daily living;
sweep and vacuum

−1.45

0.97

Batting.

−2.51

−15.70
– 10.70

Weight moving.

−4.81

−22.50
– 12.90

Walking.

−1.68

−15.60
– 12.20

Rawstorn
12 Lead Treadmill Running
−0.30
et al.
ECG
(2015). [22]
Treadmill, Cycle Ergometer 1.10
and Activities of daily
living; sweep and vacuum

−21.87
– 9.26

Kim et al.
(2013). [25]

12-Lead
ECG

Treadmill running

Flanagan et
al. (2014).
[27]

5 Lead
ECG

Cycle ergometer

Smith et al.
(2014). [29]

Gatti et al.
(2014). [26]

Rawstorn et
al. (2015).
[22]

3 Lead
ECG

5 Lead
EKG

12 Lead
ECG

Table 5 Summary of agreement properties of ZB

Testing protocol

Johnstone et Polar-T31 Walk-Jog-Run
al. (2012). [1]
All Velocities

Dolezal et al. 12 Lead
(2014). [28]
ECG

Page 6 of 8

ZB zephyr bioharness, Mean diff mean difference, r Pearson’s correlation
coefficient, rs spearman’s rank correlation

5.90) during various physical activities, and excellent
ICC ≥ 0.90 (SEM ≤ 3.51) at resting and recovery phases
[1, 2, 22, 23].
Validity coefficients quantify the linear relationship between two measures /devices [15]. However, the coefficients do not provide information regarding the extent of
systematic error (lack of agreement) between two devices.
Since it is very rare to obtained two identical findings
while assessing the same construct using two different devices, reporting of the magnitude of the agreement is necessary [15]. Reporting of individual agreement in terms
of 95% limits of agreement (LoA), put forward by Bland
and Altman, is important to assess agreement parameters
and whether the devices can be used interchangeably [15].

Cycle ergometer

12 Lead Treadmill Walk
ECG

Smith et al. 3 Lead
(2014). [29] ECG

Gatti et al. 5 Lead
(2014). [26] EKG

−13.39
– 23.79

ZB zephyr bioharness, 95% LoA limits of agreement

In this review, the validity of ZB heart rate variable against
Polar T31 (ZB vs. Polar T31), and against gold standard
criterion measure (ZB vs. ECG) yielded similar, strong to
very strong correlation coefficients. However, the pairwise agreement parameters between ZB vs. Polar T31
(two studies), and ZB vs. ECG (six studies) varied. The
Johnstone et al. [1] and Johnstone et al. [24] studies, were

Nazari et al. BMC Sports Science, Medicine and Rehabilitation (2018) 10:6

both rated at “Very good”. However, agreement did
not establish ZB agreement parameters against a gold
standard criterion – ECG; instead compared ZB
against Polar T31, nor provided any literature on the
measurement properties of Polar T31 [1, 24]. Both
studies reported wide 95% LoA. The lack of comparison against a gold standard criterion measure, and
paucity of reports on the measurement properties of
Polar T31, could have contributed to such wide 95%
LoA. In regards to ZB vs ECG comparisons, Flanagan
et al. [27] study rated at “Very good”, reported (−
2.84–2.42) 95% LoA. Similarly, Dolezal et al. [28] and
Smith et al. [29] studies rated at “Good”, reported (−
0.21–0.14) and (− 3.01–0.70) 95% LoA between ZB vs
ECG respectively. It is important to note that there
are no thresholds to help categorized 95% LoA into
excellent or poor, however, narrower 95% LoA between ZB vs ECG, is suggestive of better agreement
and possible interchangeable use. On the contrary,
three studies, Kim et al. [25], Rawstorn et al. [22] and
Gatti et al. [26] reported somewhat wider 95% LoA in
pair-wise device comparisons between ZB vs ECG.
However, these studies had lower methodological
scores [22, 25, 26]. Therefore, studies with higher
methodological quality scores that assessed ZB vs
ECG agreements, displayed narrower 95% LoA than
studies with lower methodological scores.
Potential benefits of wearable technologies might include enhanced safety, better targeting of exercise to
capability, better motivation and adherence. It might
also allow for better progression of exercise interventions. While future studies might need to focus on the
validity and utility of these devices in health promotion,
monitoring or rehabilitation. The measurement studies
to date are supportive of testing such applications.
The findings of our review must be considered in
light of potential methodological applications. A variety of critical appraisal tools are available and the
classification of quality varies across instruments.
The Zephyr BioHarness measures a variety of other
physiological indicators other than just heart rate,
and we did not assess the reliability or validity of
these other measurements. Finally, better measurement is the first step in the clinical process, and the
downstream effects of using Zephyr need to be more
fully investigated.

Conclusion
Good to excellent quality evidence from ten studies suggested that the Zephyr Bioharness device can provide reliable and valid measurements of heart rate across
multiple contexts, and that it displayed good agreements
with gold standard measurements.
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Additional file 1: Description of data: Quality Appraisal of a Clinical
Measurement Study Tool and Interpretation Guide. (DOCX 38 kb)
Abbreviations
CID: Clinically important difference; ICC: Intra-class correlation coefficient;
LoA: Limits of agreement; MCID: Minimal clinically important difference;
MID: Minimal important difference; r: Pearson’s correlation coefficients;
rs: Spearman’s correlation coefficients; SEM: Standard error of measurement;
WPM: Wearable physiological monitoring; ZB: Zephyr bioharness
Acknowledgements
This work was supported by an operating grant from the Ontario Ministry of
Labour - Grant Number #13-R-027. The funding body had no role in design,
in the collection, analysis, and interpretation of data, in the writing of the
manuscript, or in the decision to submit the manuscript for publication.
Funding
No funding was obtained for this study.
Availability of data and materials
Not Applicable.
Authors’ contributions
GN contributed significantly to conception and design of the study, data
extraction, critical appraisal, interpretation of data and drafting of the
manuscript. PB was involved in data extraction, critical appraisal and drafting.
JM was also involved in the conception and design of the study, drafting,
and revised the manuscript for important intellectual content. KS, JR and AT
were involved in the drafting and review of the manuscript. All authors have
given their final approval on the manuscript to be published.
Ethics approval and consent to participate
Not Applicable.
Consent for publication
Not Applicable
Competing interests
The authors declare that they have no competing interests.

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1
Physical Therapy, Western University, London, ON, Canada. 2Roth McFarlane
Hand and Upper Limb Centre, St. Joseph’s Hospital, London, ON, Canada.
3
School of Kinesiology, Lakehead University, 955 Oliver Road, Thunder Bay,
ON, Canada. 4McMaster University, School of Rehabilitation Science, 1400
Main Street West, Hamilton, ON, Canada.
Received: 7 March 2017 Accepted: 29 January 2018

References
1. Johnstone JA, Ford PA, Hughes G, Watson T, ACS M, Garrett AT. Field based
reliability and validity of the bioharness™ multivariable monitoring device. J
Sports Sci Med. 2012;11:643–52.
2. Johnstone JA, Ford PA, Hughes G, Watson T, Garrett AT. Bioharness™
multivariable monitoring device: part II: reliability. J Sports Sci Med. 2012b;
11(3):409–17.
3. Bianchi W, Freyer-Dugas A, Hsieh YH, Saheed M, Hill P, Lindauer C, Terzis A,
Rothman RE. Revitalizing a vital sign: improving detection of Tachypnea at
primary triage. Ann Emerg Med. 2013;61(1):37–43.
4. Yang C, Hsu Y. A review of Accelerometry-based wearable motion detectors
for physical activity monitoring. Sensors. 2010;10:7772–88.

Nazari et al. BMC Sports Science, Medicine and Rehabilitation (2018) 10:6

5.

6.

7.
8.

9.
10.
11.

12.

13.
14.

15.
16.

17.

18.

19.
20.
21.
22.

23.

24.
25.

26.
27.

28.

29.

Collier R, Randolph AB. Wearable Technologies for Healthcare Innovation.
Hilton Head Island: Proceedings of the Southern Association for Information
Systems Conference; 2015.
Zephyr Technology. BioHarness 3.0 User ManualBioHarness 3.0 User Manual.
Retrieved from 2012. https://www.zephyranywhere.com/resources/
omnisense-software. Accessed Feb 2018.
Borresen J, Lambert MI. Quantifying training load: a comparison of subjective
and objective methods. Int J Sports Physiol Perform. 2008;3:16–30.
Buchheit M, Simpson MB, Al Haddad H, Bourdon PC, Mendez-Villanueva A.
Monitoring changes in physical performance with heart rate measures in
young soccer players. Eur J Appl Physiol. 2012;112:711–23.
Hopkins WG. Quantification of training in competitive sports. Methods and
applications. Sports Med. 1991;12:161–83.
Astrand PO, Ryhming I. Nomogram for calculations of aerobic capacity from
pulse rate during submaximal work. J Appl Physiol. 1954;7:218.
Daanen HAM, Lamberts RP, Kallen VL, Jin A, Van Meeteren NLU. A
systematic review on heart-rate recovery to monitor changes in training
status in athletes. Int J Sports Physiol Perform. 2012;7:251–60.
Brage S, Westgate K, Franks PW, Stegle O, Wright A, Ekelund U, Wareham NJ.
Estimation of free-living energy expenditure by heart rate and movement
sensing: a doubly-Labelled water study. PLoS One. 2015;10(9):e0137206.
Streiner DL, Norman GR. Health measurement scales: a practical guide to their
development and use. 2nd ed. New York: Oxford University Press; 1995.
De Bruin AF, Diederiks JPM, De Witte LP, Stevens FCJ, Philipsen H. Assessing
the responsiveness of a functional status measure: the sickness impact
profile versus the SIP68. J Clin Epidemiol. 1997;50(5):529–40.
Bland JM, Altman DG. Statistical methods for assessing agreement between
two methods of clinical measurement. Lancet. 1986;327(8476):307–10.
MacDermid JC. Critical appraisal of study quality for psychometric articles,
evaluation form. In: Law M, MacDermid JC, editors. Evidence-based
rehabilitation. Thorofare: Slack Inc; 2008. p. 387–8.
MacDermid JC. Critical appraisal of study quality for psychometric articles,
interpretation guide. In: Law M, MacDermid JC, editors. EvidenceBased
rehabilitation. Thorofare: Slack Inc; 2008. p. 389–92.
Roy JS, Desmeules F, MacDermid JC. Psychometric properties of
presenteeism scales for musculoskeletal disorders: a systematic review. J
Rehabil Med. 2011;43(1):23–31(9).
Rosner B. Fundamentals of biostatistics. 6th ed. Boston: Duxbury Press; 2005.
Evans JD. Straightforward statistics for the behavioral sciences. Pacific Grove:
Brooks/Cole Publishing; 1996.
Bunce C. Correlation, agreement, and bland–Altman analysis: statistical
analysis of method comparison studies. Am J Ophthalmol. 2009;148(1):4–6.
Rawstorn JC, Gant N, Warren I, Doughty RN, Lever N, Poppe KK, Maddison R.
Measurement and data transmission: validity of a multi-biosensor system for
real-time remote exercise monitoring among cardiac patients. JMIR Rehabil
Assist Technol. 2015;2(1):e2.
Nazari G, MacDermid JC, Kathryn SE, Richardson J, Tang A. Reliability of
Zephyr bioharness and Fitbit charge measures of heart rate and activity at
rest, during the modified Canadian aerobic fitness test and recovery. J
Strength Cond Res. 2017; https://doi.org/10.1519/JSC.0000000000001842.
Johnstone JA, Ford PA, Hughes G, Watson T, Garrett AT. BioharnessTM
multivariable monitoring device: part I: validity. J Sports Sci Med. 2012a;11(3):400–8.
Kim JH, Roberge R, Powell JB, Shafer AB, Williams WJ. Measurement
accuracy of heart rate and respiratory rate during graded exercise and
sustained exercise in the heat using the Zephyr bioharness TM. Int J Sports
Med. 2013;34:497–501.
Gatti UC, Schneider S, Migliaccio GC. Physiological condition monitoring of
construction workers. Autom Constr. 2014;44:227–33.
Flanagan SD, Comstock BA, Dupont WH, Sterczala AR, Looney DP,
Dombrowski DH, et al. Concurrent validity of the armour39 heart rate
monitor strap. J Strength Cond Res. 2014;28(3):870–3.
Dolezal BA, Boland DM, Carney J, Abrazado M, Smith DL, Cooper CB.
Validation of heart rate derived from a physiological status monitorembedded compression shirt against criterion ECG. J Occup Environ Hyg.
2014;11:833–9.
Smith DL, Haller JM, Dolezal BA, Cooper CB, Fehling PC. Evaluation of a
wearable physiological status monitor during simulated fire fighting
activities. J Occup Environ Hyg. 2014;11:427–33.

Page 8 of 8

Submit your next manuscript to BioMed Central
and we will help you at every step:
• We accept pre-submission inquiries
• Our selector tool helps you to find the most relevant journal
• We provide round the clock customer support
• Convenient online submission
• Thorough peer review
• Inclusion in PubMed and all major indexing services
• Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit

